Validation of the Swedish version of the Beliefs about Medicines Questionnaire, based on people with epilepsy
(2021) In Epilepsy and Behavior 115.- Abstract
- Title
Validation of the Swedish version of the Beliefs about Medicines Questionnaire, based on people with epilepsy.
Purpose
The aims of the study were to explore the latent structure of the Swedish Beliefs about Medicines Questionnaire (BMQ), to investigate its reliability and to identify the extent to which individual factors among people with epilepsy (PWE), as well as their general beliefs about medication, predict their beliefs about their specific anti-seizure drugs (ASDs).
Methods
One-hundred and fifty six included study participants diagnosed with epilepsy and with a well-established neurological follow-up completed an array of rating scales. Included were the Swedish BMQ, which captures beliefs about medicines,... (More) - Title
Validation of the Swedish version of the Beliefs about Medicines Questionnaire, based on people with epilepsy.
Purpose
The aims of the study were to explore the latent structure of the Swedish Beliefs about Medicines Questionnaire (BMQ), to investigate its reliability and to identify the extent to which individual factors among people with epilepsy (PWE), as well as their general beliefs about medication, predict their beliefs about their specific anti-seizure drugs (ASDs).
Methods
One-hundred and fifty six included study participants diagnosed with epilepsy and with a well-established neurological follow-up completed an array of rating scales. Included were the Swedish BMQ, which captures beliefs about medicines, scales for symptoms of anxiety and depression and sense of self-efficacy, as well as a general questionnaire regarding their social situation in general. Statistical analysis included Principal Component Analyses (PCA) and hierarchical multiple regression analysis.
Results
The PCA revealed a two-factor structure for each of the BMQ-subscales with acceptable (BMQ-G) to high (BMQ-S) internal consistency. The only individual factor that predicted variance in beliefs about medication was patient gender, where levels of both anxiety and depression were elevated in women.
Conclusion
The Swedish BMQ exhibits psychometric features indicating its reliable use in adult PWE. Our results suggest that the BMQ provides information about the patients’ view of their medication regardless of their general mood and that women hold stronger beliefs of concern beyond influence from their levels of depression and anxiety.
(Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/45c26218-130c-470f-90b1-f28ef3870d51
- author
- Compagno Strandberg, Maria LU ; Olsson, Patrik LU ; Hedenrud, Tove ; Kallen, Kristina LU and Psouni, Elia LU
- organization
- publishing date
- 2021
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Epilepsy and Behavior
- volume
- 115
- article number
- 107615
- publisher
- Elsevier
- external identifiers
-
- scopus:85098231715
- pmid:33383481
- ISSN
- 1525-5069
- DOI
- 10.1016/j.yebeh.2020.107615
- language
- English
- LU publication?
- yes
- id
- 45c26218-130c-470f-90b1-f28ef3870d51
- date added to LUP
- 2020-10-13 09:17:53
- date last changed
- 2024-02-01 06:30:54
@article{45c26218-130c-470f-90b1-f28ef3870d51, abstract = {{Title<br/>Validation of the Swedish version of the Beliefs about Medicines Questionnaire, based on people with epilepsy.<br/>Purpose<br/>The aims of the study were to explore the latent structure of the Swedish Beliefs about Medicines Questionnaire (BMQ), to investigate its reliability and to identify the extent to which individual factors among people with epilepsy (PWE), as well as their general beliefs about medication, predict their beliefs about their specific anti-seizure drugs (ASDs).<br/>Methods<br/>One-hundred and fifty six included study participants diagnosed with epilepsy and with a well-established neurological follow-up completed an array of rating scales. Included were the Swedish BMQ, which captures beliefs about medicines, scales for symptoms of anxiety and depression and sense of self-efficacy, as well as a general questionnaire regarding their social situation in general. Statistical analysis included Principal Component Analyses (PCA) and hierarchical multiple regression analysis.<br/>Results<br/>The PCA revealed a two-factor structure for each of the BMQ-subscales with acceptable (BMQ-G) to high (BMQ-S) internal consistency. The only individual factor that predicted variance in beliefs about medication was patient gender, where levels of both anxiety and depression were elevated in women.<br/>Conclusion<br/>The Swedish BMQ exhibits psychometric features indicating its reliable use in adult PWE. Our results suggest that the BMQ provides information about the patients’ view of their medication regardless of their general mood and that women hold stronger beliefs of concern beyond influence from their levels of depression and anxiety.<br/>}}, author = {{Compagno Strandberg, Maria and Olsson, Patrik and Hedenrud, Tove and Kallen, Kristina and Psouni, Elia}}, issn = {{1525-5069}}, language = {{eng}}, publisher = {{Elsevier}}, series = {{Epilepsy and Behavior}}, title = {{Validation of the Swedish version of the Beliefs about Medicines Questionnaire, based on people with epilepsy}}, url = {{http://dx.doi.org/10.1016/j.yebeh.2020.107615}}, doi = {{10.1016/j.yebeh.2020.107615}}, volume = {{115}}, year = {{2021}}, }